Researcher
Iwein Gyselinck
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Aug 2019 → Today
Projects
1 - 1 of 1
- Azithromycin for Chronic Obstructive Pulmonary Disease: A Patient-tailored PrescriptionFrom1 Aug 2019 → 17 Jan 2024Funding: FWO fellowships
Publications
11 - 20 of 24
- Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Quentin Van Thillo, Iwein Gyselinck, Caroline Martens, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, et al.
- Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?(2022)
Authors: Iwein Gyselinck, Wim Janssens
Pages: 1125 - 1126 - Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge(2022)
Authors: Natalie Lorent, Walter De Wever, Iwein Gyselinck, Stephanie Everaerts, Heleen Demeyer, Laurent Godinas, Lieven Dupont, Greet Hermans, Rik Gosselink, Wim Janssens
- Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma(2022)
Authors: Timothy Devos, Quentin Van Thillo, Iwein Gyselinck, Piet Maes, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt
- Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)(2022)
Authors: Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Wim Janssens, Robin Vos
- Remdesivir, on the road to DisCoVeRy.(2021)
Authors: Iwein Gyselinck, Wim Janssens
Pages: 1 - 2 - Distinct Airway Involvement in Subtypes of End-Stage Fibrotic Pulmonary Sarcoidosis(2021)
Authors: Stijn Verleden, Arno Vanstapel, Laurens De Sadeleer, Tinne Goos, Iwein Gyselinck, Vincent Geudens, Janne Kaes, Dirk Van Raemdonck, Laurens Ceulemans, Jonas Yserbyt, et al.
Pages: 562 - 571 - itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)(2021)
Authors: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Bert Vandenberk, Lorenz Van der Linden, et al.
- Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial(2021)
Authors: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Vincent Geldhof, et al.
- Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin (vol 22, 126, 2021)(2021)
Authors: Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, Wim Janssens
Pages: 0 - 0